Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jörn, Bramstedt"'
Autor:
Linus A. Völker, Jessica Kaufeld, Gesa Balduin, Lena Merkel, Lucas Kühne, Dennis A. Eichenauer, Thomas Osterholt, Holger Hägele, Martin Kann, Franziska Grundmann, Benedikt Kolbrink, Kevin Schulte, Anja Gäckler, Andreas Kribben, Kristina Boss, Sebastian A. Potthoff, Lars C. Rump, Tilman Schmidt, Anja S. Mühlfeld, Karsten Schulmann, Matthias Hermann, Jens Gaedeke, Kristin Sauerland, Jörn Bramstedt, Ulrich P. Hinkel, Wolfgang Miesbach, Frederic Bauer, Timm H. Westhoff, Heike Bruck, Veronika Buxhofer-Ausch, Tobias J. Müller, Ralph Wendt, Ana Harth, Adrian Schreiber, Evelyn Seelow, Markus Tölle, Christopher Gohlisch, Markus Bieringer, Gesa Geuther, Wolfram J. Jabs, Michael Fischereder, Anke von Bergwelt-Baildon, Ulf Schönermarck, Paul Knoebl, Jan Menne, Paul T. Brinkkoetter, Fedai Özcan, Silke Markau, Matthias Girndt, Helmut Felten, Martin Hausberg, Marcus Brand, Jens Gerth, Martin Bommer, Stefan Zschiedrich, Johanna Schneider, Saban Elitok, Alexander Gawlik, Vedat Schwenger, Maximilian Roeder, Jörg Radermacher, Anke Morgner, Regina Herbst, Charis von Auer
Publikováno v:
Journal of Thrombosis and Haemostasis. 21:559-572
BACKGROUND: The von Willebrand factor-directed nanobody caplacizumab has greatly changed the treatment of immune thrombotic thrombocytopenic purpura (iTTP) in recent years. Data from randomized controlled trials established efficacy and safety. OBJEC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eab16496bb47c27f67f0167cb5337e3
https://doi.org/10.1016/j.jtha.2022.11.010
https://doi.org/10.1016/j.jtha.2022.11.010
Autor:
Martin Bommer, Silke Markau, Wolfram J. Jabs, Charis von Auer, Markus Bieringer, Paul T. Brinkkoetter, Martin Reinhardt, Regina Herbst, Sebastian Brähler, Anja Mühlfeld, Jörg Radermacher, Frederic Bauer, Ralph Wendt, Johanna Schneider, Jan Menne, Hildegard Christ, Alexander Gawlik, Lucas Kühne, Timm H. Westhoff, Saban Elitok, Wolfgang Miesbach, Anja Gäckler, Sebastian A. Potthoff, Jens Gerth, Helmut Felten, M. Tölle, Fedai Özcan, Maximilian Roeder, Jörn Bramstedt, Jessica Kaufeld, Andreas Kribben, Martin Hausberg, Anke Morgner, Jens Gaedeke, Linus A. Völker, Marcus Brand, Stefan Zschiedrich, Adrian Schreiber, Ulf Schoenermarck, Vedat Schwenger, Ana Harth, Matthias Girndt
Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare but life-threatening condition. In 2018, the nanobody caplacizumab was approved for the treatment of adults experiencing an acute episode of aTTP, in conjunction with plasma exchange (PEX)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3da1d0e9664bad0a2333cb332710f7d7
http://edoc.mdc-berlin.de/19118/1/19118oa.pdf
http://edoc.mdc-berlin.de/19118/1/19118oa.pdf
Autor:
M. Tölle, Wolfram J. Jabs, Fedai Özcan, Lucas Kühne, Jan Menne, Regina Herbst, Timm H. Westhoff, Paul T. Brinkkoetter, Sebastian A. Potthoff, Andreas Kribben, Vedat Schwenger, Alexander Gawlik, Martin Reinhardt, Silke Markau, Ralph Wendt, Anke Morgner, Anja Mühlfeld, Ana Harth, Saban Elitok, Wolfgang Miesbach, Jörg Radermacher, Johanna Schneider, Martin Hausberg, Charis von Auer, Martin Bommer, Markus Bieringer, Maximilian Roeder, Jörn Bramstedt, Frederic Bauer, Helmut Felten, Ulf Schoenermarck, Matthias Girndt, Hildegard Christ, Jessica Kaufeld, Anja Gäckler, Jens Gerth, Jens Gaedeke, Sebastian Brähler, Adrian Schreiber, Linus A. Völker, Marcus Brand, Stefan Zschiedrich
Publikováno v:
Blood Adv
Introduction of the nanobody caplacizumab was shown to be effective in the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in the acute setting. The official recommendations include plasma exchange (PEX), immunosuppression, and the u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::925b2ff5793d83294a1ac70f7d152044
http://edoc.mdc-berlin.de/19119/1/19119oa.pdf
http://edoc.mdc-berlin.de/19119/1/19119oa.pdf
Autor:
Uwe Kuhlmann, Eiske M. Dorresteijn, Jürgen Steinhoff, Tobias N. Meyer, Jens Nürnberger, Frank Merkel, Gernot Beutel, Wolfgang Ries, Steffen Mitzner, Miriam Abu-Tair, Ulf Panzer, Reinhard Brunkhorst, Veit Busch, Peter Gerke, Susanne Fleig, Bernd Sucke, Norbert Klause, Sabine Schnatter, Carsten Hafer, Martin Vischedyk, Sylvia Stracke, Ralf Schindler, Ola Samuelsson, Monika Wiesner, Andreas Kribben, Jan T. Kielstein, Stefan Mees, Jörn Bramstedt
Publikováno v:
Nephrology Dialysis Transplantation
BACKGROUND May 22nd marks the beginning of a Shiga-toxin-producing Escherichia coli (STEC) O104:H4 outbreak in Northern Germany. By its end on 27 July, it had claimed 53 deaths among 2987 STEC and 855 confirmed haemolytic-uraemic syndrome (HUS) cases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f06789caeef8b817e3345c6ea9db829
https://doi.org/10.1093/ndt/gfs394
https://doi.org/10.1093/ndt/gfs394
Publikováno v:
Clinical Pulmonary Medicine. 18:319-320
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3df0d12f2dbef87f0ab53e64d6b5d538
https://doi.org/10.1097/cpm.0b013e318234d2b3
https://doi.org/10.1097/cpm.0b013e318234d2b3
Autor:
Jan, Menne, Martin, Nitschke, Robert, Stingele, Mariam, Abu-Tair, Jan, Beneke, Jörn, Bramstedt, Jan P, Bremer, Reinhard, Brunkhorst, Veit, Busch, Reinhard, Dengler, Günther, Deuschl, Klaus, Fellermann, Helmut, Fickenscher, Christoph, Gerigk, Alexander, Goettsche, Jobst, Greeve, Carsten, Hafer, Friedrich, Hagenmüller, Hermann, Haller, Stefan, Herget-Rosenthal, Bernd, Hertenstein, Christina, Hofmann, Melanie, Lang, Jan T, Kielstein, Ulrich C, Klostermeier, Johannes, Knobloch, Markus, Kuehbacher, Ulrich, Kunzendorf, Hendrik, Lehnert, Michael P, Manns, Tobias F, Menne, Tobias N, Meyer, Claus, Michael, Thomas, Münte, Christine, Neumann-Grutzeck, Jens, Nuernberger, Hermann, Pavenstaedt, Leyla, Ramazan, Lutz, Renders, Jonas, Repenthin, Wolfgang, Ries, Axel, Rohr, Lars Christian, Rump, Ola, Samuelsson, Friedhelm, Sayk, Bernhard M W, Schmidt, Sabine, Schnatter, Harald, Schöcklmann, Stefan, Schreiber, Cay U, von Seydewitz, Jürgen, Steinhoff, Sylvia, Stracke, Sebastian, Suerbaum, Andreas, van de Loo, Martin, Vischedyk, Karin, Weissenborn, Peter, Wellhöner, Monika, Wiesner, Sebastian, Zeissig, Jürgen, Büning, Mario, Schiffer, Tanja, Kuehbacher, Karl W, Kroencke
Publikováno v:
BMJ. 345:e4565-e4565
Objective To evaluate the effect of different treatment strategies on enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome. Design Multicentre retrospective case-control study. Setting 23 hospitals in northern Germany. Part
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50551c6f02607e5dfcef280b718c9321
https://doi.org/10.1136/bmj.e4565
https://doi.org/10.1136/bmj.e4565